Cisplatin, continuous-infusion 5-fluorou
โ
Catherine A. Wheeler; Lawrence N. Shulman; Steven E. Come; Lowell E. Schnipper;
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 377 KB
๐ 2 views
Forty-one patients with unresectable non-small cell carcinoma of the lung (NSCCL) were treated with cisplatin 20 mg/m2/d for 5 days as a daily bolus injection, 5-fluorouracil 800 mg/m2/d by continuous infusion for 5 days, and intermediate-dose methotrexate 200 mg/m2 on days 15 and 22 of a 28-day cyc